ey0020.3-7 | Advances in Clinical Practice | ESPEYB20
W Zhou , JG van Rooij , DM van de Laarschot , Z Zervou , H Bruggenwirth , NM Appelman-Dijkstra , PR Ebeling , S Demirdas , AJ Verkerk , MC Zillikens
ey0020.7-1 | Gonadal Function and Fertility Issues in Childhood Cancer Survivors | ESPEYB20
I Masliukaite , E Ntemou , EAM Feijen , M van de Wetering , A Meissner , AT Soufan , S Repping , LMC Kremer , K Jahnukainen , E Goossens , AMM van Pelt
ey0018.4-8 | Growth Hormone Therapy: Safety | ESPEYB18
Goedegebuure Wesley J. , van der Steen Manouk , Kerkhof Gerthe F , Hokken-Koelega Anita CS
ey0018.6-10 | Patient Related Outcomes | ESPEYB18
Duranteau Lise , Rapp Marion , van de Grift Tim C , Hirschberg Angelica L
ey0018.6-15 | Longterm Effects of Hormonal Treatments in Gender Dysphoria | ESPEYB18
MA van der Loos , I Hellinga , MC Vlot , DT Klink , M den Heijer , CM Wiepjes
ey0018.9-3 | Childhood cancer and thyroid disease | ESPEYB18
SC Clement , CA Lebbink , MS Klein Hesselink , JC Teepen , TP Links , CM Ronckers , HM van Santen
ey0019.3-12 | Autoimmune Thyroid Disease | ESPEYB19
CF Mooij , TD Cheetham , FA Verburg , A Eckstein , SH Pearce , J Leger , ASP van Trotsenburg
ey0019.6-12 | Gender Incongruence: Growth and fertility in transgender girls | ESPEYB19
LS Boogers , CM Wiepjes , DT Klink , I Hellinga , Trotsenburg ASP van , Heijer M den , SE Hannema
ey0019.6-15 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19
M Arnoldussen , der Miesen AIR van , WS Elzinga , AE Alberse , A Popma , TD Steensma , Vries ALC de
ey0017.8-15 | New Concerns | ESPEYB17
Westeinde A Vant , L Karlsson , Sandberg M Thomsen , A Nordenstrom , N Padilla , S Lajic